欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
AT/H/0496/001
药品名称
ELEVIT
活性成分
RETINOL palmitate 2566.0 I.U.
Pyridoxine hydrochloride 1.9 mg
Potassium iodide 220.0 µg
Nicotinamide 18.0 mg
MANGANESE sulfate 2.0 mg
Magnesium oxide 100.0 mg
Fumaric acid iron salt 45.0 mg
Folic acid 800.0 µg
cyanocobalamin (57Co) 2.6 µg
Copper 1.0 mg
Colecalciferol 200.0 I.U.
Calcium pantothenate 6.0 mg
Calcium phosphate 125.0 mg
Biotin 30.0 µg
Ascorbic acid 85.0 mg
ALPHATOCOPHEROL ACETATE 15.0 mg
Zinc citrate 11.0 mg
Thiamine nitrate 1.4 mg
Sodium selenite 50.0 µg
Riboflavin nitrate 1.4 mg
剂型
Film-coated tablet
上市许可持有人
Bayer plc, Bayer Healthcare Consumer Care
参考成员国 - 产品名称
Austria (AT)
互认成员国 - 产品名称
Romania (RO)
Elevit
Poland (PL)
Latvia (LV)
Estonia (EE)
Hungary (HU)
Bulgaria (BG)
Luxembourg (LU)
Cyprus (CY)
许可日期
2013/01/26
最近更新日期
2019/01/02
药物ATC编码
A11AA03 multivitamins and other minerals, incl. combinations
申请类型
TypeLevel1：
TypeLevel2：
TypeLevel3：
TypeLevel4：
TypeLevel5：
附件文件下载
Final PL
|
AT H 0496 001 IB 027 _ 1_3_1_common_pl_clean
Date of last change:2024/09/06
PubAR
|
AT_H_0496_001_PAR_Elevit_Plus
Date of last change:2024/09/06
Final Product Information
|
ATH0496_001_II020_PL_clean_final
Date of last change:2024/09/06
Final SPC
|
final_AT H 0496 001 _ II_25 common_spc_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2026
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase